Intracranial tumors in Kuwait: a 15-year survey
The dearth of literature on intracranial tumors (ICT) in Kuwait has necessitated this study whose objective is epidemiological. It is based on the records of the Department of Pathology, Al-Sabah Hospital, Kuwait, where virtually all brain biopsies in Kuwait were examined. Between 1995 and 2009, 439 males (53.41%) and 383 females (46.59%) had primary intracranial tumors (PICT). Most (69%) were younger than 50 years, with 16% children and adolescents and 4% elderly (≥70 years); meningioma (28%), pituitary adenoma (19%), glioblastoma (15%), astrocytoma (13%), and medulloblastoma (5%) were the most common. In childhood and adolescence, astrocytoma (35.34%) and medulloblastoma (22.56%) predominated. The mean age-adjusted incidence rate/100,000 was: PICT: 3.02; astrocytic tumors: 0.93; meningioma: 0.96; pituitary adenoma: 0.44; and medulloblastoma: 0.13. All showed a declining trend which was only statistically significant for medulloblastoma (P = 0.007). A modest correlation between the percentage of elderly in the general population and incidence rates was found (r = 0.411). Tumors with significant male preponderance were high-grade astrocytic tumors, silent pituitary adenoma (SA), and nerve sheath tumor. Meningioma had a female to male ratio of 2.24. The peak frequency for functional pituitary adenoma and females was in the age range of 20–29 years, while for SA and males it was 40–49 years. About 5% of ICT were metastatic, with cancers of breast (26%), lung (17%) and gastrointestinal (11%) origin as the most common. In conclusion, the epidemiology of PICT in Kuwait is characterized by low incidence rates and a distinct age distribution.
KeywordsIntracranial tumors Astrocytic tumors Meningioma Pituitary adenoma
Conflict of interest
There was neither sponsorship nor funds from any source for this work. All authors do not have any conflict of interest.
- 5.El basmi A, Al Asfour A (2006) Kuwait cancer registry annual report. Ministry of Health, KuwaitGoogle Scholar
- 6.Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–1957). Department of Public Health, Tohoku University of Medicine, SendaiGoogle Scholar
- 7.Wesseling P, von Delmling A, Aldape KD (2007) Metastatic tumors of the CNS. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (ed) WHO classification of tumors of the central nervous system, 4th edn. IARC, LyonGoogle Scholar
- 9.CBTRUS (2010) CBTRUS Statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004–2006. Source: Central Brain Tumor Registry of the United States, Hinsdale, IL. Website: www.cbtrus.org
- 10.Cancer Research UK (2010) Brain and central nervous system tumours- UK incidence statistics. http://info.cancerresearchuk.org/cancerstats/types/brain/incidence/index.htm. Accessed 1 September 2010
- 11.Kuratsu J, Takeshima H, Ushio Y (2001) Trends in the incidence of primary intracranial tumors in Kumamoto. Jpn Int J Clin Oncol. 6:183–191Google Scholar
- 12.Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA (2008) Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113:1953–1968PubMedCrossRefGoogle Scholar
- 15.Source: Population statistics-Public Authority of Civil Information, KuwaitGoogle Scholar
- 16.US Census Bureau (2010) USA QuickFacts. www.census.gov/2010census. Accessed 3 September 2010
- 18.Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS (1999) Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382–1390; Erratum in: J Natl Cancer Inst 91:1693Google Scholar
- 19.Bouffet E, Matsutani (2005) Epidemiology of intracranial germ cell tumours (ICGCT). In: Abstracts for the second international symposium on central nervous system germ cell tumors, November 18–21, 2005, Los Angeles, California. Neuro Oncol 7: 513–533Google Scholar